|
Name |
Piperitone oxide
|
Molecular Formula | C10H16O2 | |
IUPAC Name* |
6-methyl-3-propan-2-yl-7-oxabicyclo[4.1.0]heptan-2-one
|
|
SMILES |
CC(C)C1CCC2(C(C1=O)O2)C
|
|
InChI |
InChI=1S/C10H16O2/c1-6(2)7-4-5-10(3)9(12-10)8(7)11/h6-7,9H,4-5H2,1-3H3
|
|
InChIKey |
IAFONZHDZMCORS-UHFFFAOYSA-N
|
|
Synonyms |
Piperitone oxide; 1,2-Epoxy-p-menthane-3-one; 5286-38-4; Pipertone, oxide; Piperitone 1-oxide; Piperitoneoxide; p-Menthan-3-one, 1,2-epoxy-; 6-methyl-3-propan-2-yl-7-oxabicyclo[4.1.0]heptan-2-one; 7-Oxabicyclo[4.1.0]heptan-2-one, 6-methyl-3-(1-methylethyl)-; 7-Oxabicyclo(4.1.0)heptan-2-one, 6-methyl-3-(1-methylethyl)-; UNII-88UA85L5VI; Piperitonoxid; Piperiton epoxid; EINECS 226-125-2; NSC 316068; p-Menthan-3-one,2-epoxy-; SCHEMBL909590; 88UA85L5VI; DTXSID1052167; 6-Methyl-3-(propan-2-yl)-7-oxabicyclo[4.1.0]heptan-2-one; NSC316068; NSC-316068; FT-0699759; 3-Isopropyl-6-methyl-7-oxabicyclo[4.1.0]heptan-2-one #; 6-Methyl-3-(1-methylethyl)-7-oxabicyclo(4.1.0)heptan-2-one
|
|
CAS | 5286-38-4 | |
PubChem CID | 92998 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 168.23 | ALogp: | 1.8 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 29.6 | Aromatic Rings: | 2 |
Heavy Atoms: | 12 | QED Weighted: | 0.562 |
Caco-2 Permeability: | -4.373 | MDCK Permeability: | 0.00002590 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.014 |
Blood-Brain-Barrier Penetration (BBB): | 0.893 | Plasma Protein Binding (PPB): | 61.54% |
Volume Distribution (VD): | 1.702 | Fu: | 38.93% |
CYP1A2-inhibitor: | 0.075 | CYP1A2-substrate: | 0.718 |
CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.917 |
CYP2C9-inhibitor: | 0.039 | CYP2C9-substrate: | 0.102 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.455 |
CYP3A4-inhibitor: | 0.024 | CYP3A4-substrate: | 0.377 |
Clearance (CL): | 14.569 | Half-life (T1/2): | 0.616 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.339 |
Drug-inuced Liver Injury (DILI): | 0.693 | AMES Toxicity: | 0.223 |
Rat Oral Acute Toxicity: | 0.559 | Maximum Recommended Daily Dose: | 0.032 |
Skin Sensitization: | 0.436 | Carcinogencity: | 0.115 |
Eye Corrosion: | 0.948 | Eye Irritation: | 0.821 |
Respiratory Toxicity: | 0.746 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000165 | 0.356 | D0H1QY | 0.271 | ||||
ENC001824 | 0.327 | D04CSZ | 0.245 | ||||
ENC004835 | 0.322 | D0K7LU | 0.227 | ||||
ENC002277 | 0.322 | D0S3WH | 0.222 | ||||
ENC001281 | 0.319 | D0A2AJ | 0.206 | ||||
ENC002065 | 0.316 | D0C7JF | 0.205 | ||||
ENC005928 | 0.305 | D0U3GL | 0.192 | ||||
ENC004915 | 0.300 | D04ATM | 0.188 | ||||
ENC003266 | 0.300 | D0U4VT | 0.188 | ||||
ENC000872 | 0.298 | D0V8HA | 0.185 |